Biologics Development and Manufacturing Testing: Technologies and Global Markets

Mar 2023| BIO155B| BCC Publishing

Report Highlights

The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.

Report Includes

  • 13 data tables and 16 additional tables
  • An up-to-date review and analysis of the global markets for biological safety testing and related technologies
  • Analyses of the global market trends, with market revenue data for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Discussion of market dynamics that impact the growth for biologics development and manufacturing testing, clinical applications, safety regulations, industry structure, and penetration of technologies within the biotech industry
  • Coverage of the technological, economic, and business considerations of global biological safety testing market, with analyses and growth forecasts through 2027
  • Estimation of the actual market size and revenue forecast for global biological safety testing market in USD million values, and corresponding market share analysis based on test type, application, technology, and region
  • Identification of the companies best positioned to meet the increasing demand for biological safety testing owing to their proprietary technologies, product launches, mergers and acquisitions, and other strategic advantages
  • Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the market leading players, including Catalent, Eurofins Scientific, Lonza, Merck, Thermo Fisher Scientific and WuXi AppTec

Report Scope

This report aims to provide a comprehensive study of the global market for biologics safety testing, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding biologics safety testing products and services. Biologics safety testing includes biosafety testing & characterization of raw materials, cell bank & virus seeds, unprocessed bulks/viral harvests, and drug substance/product.

This report segments the global biologics safety testing market by application, test application, testing technology, and region of operations. BCC Research analyses each market and its applications, regulatory environments, technology, market projections, and market share. Industry growth drivers, restraints, trends, and opportunities in the biological safety testing market are also discussed in detail. The report also provides information on the competitive landscape, elaborate company profiles, and the impact of COVID-19 on the biologics safety testing market.

Frequently Asked Questions (FAQs)

The global biologics safety testing market is projected to grow from $7.4 billion in 2022 to $18.2 billion in 2027, at a compound annual growth rate (CAGR) of 19.9% during the forecast period.
The global biologics safety testing market is estimated to grow at a rapid rate through 2022 to 2027 based upon a number of factors including: 1) The anticipated number of new and complex biologics that are likely to be approved for commercial use; 2) The anticipated growth in the generic biosimilars market; and 3) the increasing number of biosimilars that will be manufactured overseas (especially by CMO’s located in Asia). With a rising number of approved biological products as well as an increasing variety of therapy types and substance classes coupled with growing demand for biologics, the biologics commercial production and lot release testing market is expected to grow at the fastest rate during the forecast period.
The biologics safety testing is segmented based on test objective, test type, test technology type, and region.
Biosafety testing will dominate the market by the end of 2027.
Key companies in the market includes Charles River Laboratories International Inc. (U.S.), ThermoFisher Scientific (U.S.), WuXi AppTec (China), SGS S.A. (Switzerland), Merck KGaA (Germany), and Labcorp. (U.S.)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $6.2 billion
Market size forecast $18.2 billion
Growth rate CAGR of 19.9% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered application, test application, testing technology, and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered United States, Canada, France, Germany, Italy, Spain, United Kingdom, China, Japan, India, Latin America, Middle East, and Africa
Key Market Drivers
  • Significant Growth in Biologics Market
  • The Need for Speed to Market
  • Significant Demand for Cell and Gene Therapy Testing Services
  • Continuous Growth in Biotechnology Industry
  • Accelerating Biosimilars and Biobetters Market
Companies studied
  • SGS SA

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesMember Price
Full Report: Biologics Development and Manufacturing Testing: Technologies and Global Markets123Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Market and Technology Background6Free
Chapter- 4: Market Dynamics 13Free
Chapter- 5: Impact of the COVID-19 Pandemic4Free
Chapter- 6: Market Breakdown by Application Type16Free
Chapter- 7: Market Breakdown by Type of Test16Free
Chapter- 8: Market Breakdown by Technology 11Free
Chapter- 9: Market Breakdown by Region8Free
Chapter- 10: Competitive Landscape8Free
Chapter- 11: Company Profiles32Free
Published - Mar-2018| Analyst - David Peters| Code - BIO155A

Report Highlights

The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.

Report Includes 

  • An overview of the global market for biological safety testing and related technologies.
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of the latest market trends, regulatory environments, market projections, and market share.
  • A look at future of biological patents and biosimilars along with biologics patents by year.
  • Company profiles of major players in the industry, including Charles River Laboratories, WuXi AppTec, SGS SA, Thermo Fisher Scientific and Lonza Group.
Biologics Development and Manufacturing Testing: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.